Skip to content

Impact of using umbilical cord mesenchymal stem cell-derived exosomes to maxillofacial lesion repair

Investigating the potential benefits of healing maxillofacial lesions using exosomes derived from umbilical cord mesenchymal stem cells

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160422027520N27
Enrollment
10
Registered
2025-05-15
Start date
2025-05-22
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial and jaw lesions. Fracture of mandible

Interventions

Intervention 1: Intervention group: recipients of exosomes derived from mesenchymal stem cells in the umbilical cord. Patients with mandibular bone fractures who have been referred to the Tabriz Unive

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Jaw dislocation or fracture accompanied with chin and tooth discomfort and edema Having trouble chewing food Tooth misalignment Teeth falling out or coming loose Joint pain in the jaw and trouble expanding the mouth

Exclusion criteria

Exclusion criteria: Individuals with underlying medical conditions Individuals having issues with coagulation Patients who are above 40 and younger than 18 Individuals with a history of asthma and medication allergies

Design outcomes

Primary

MeasureTime frame
The rate of improvement of maxillofacial lesions. Timepoint: Examination of bone lesions' recovery after 1, 3, and 6 months following exosome injection. Method of measurement: using techniques from microcomputer tomography, histomorphometry, and histology. Additionally, spectroscopy, bone density measurement, and gene expression study of bone morphogenetic proteins (BMP-2).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTabriz University of Medical Sciences

Tabriz University of Medical Sciences

mehdi_yusefi@yahoo.com+98 41 3336 4665

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026